Longitudinal Trends of Comorbidities and Survival Among Kidney Cancer Patients in Asian Population

Fuente: Wiley Open Access
Enregistré dans:
Détails bibliographiques
Auteurs principaux: Minji Jung, Eunjung Choo, Jinhui Li, Zhengyi Deng, Marvin E. Langston, Sukhyang Lee, Benjamin I. Chung
Format: Artículo Open Access
Publié: Wiley 2024
Sujets:
Accès en ligne:
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
_version_ 1867002582359080960
author Minji Jung
Eunjung Choo
Jinhui Li
Zhengyi Deng
Marvin E. Langston
Sukhyang Lee
Benjamin I. Chung
author_facet Minji Jung
Eunjung Choo
Jinhui Li
Zhengyi Deng
Marvin E. Langston
Sukhyang Lee
Benjamin I. Chung
Minji Jung
Eunjung Choo
Jinhui Li
Zhengyi Deng
Marvin E. Langston
Sukhyang Lee
Benjamin I. Chung
collection Wiley Open Access
contents Longitudinal Trends of Comorbidities and Survival Among Kidney Cancer Patients in Asian Population Minji Jung Eunjung Choo Jinhui Li Zhengyi Deng Marvin E. Langston Sukhyang Lee Benjamin I. Chung Cancer Medicine ABSTRACTBackgroundComorbidity could influence cancer diagnosis, treatment, prognosis, or survival. Although comorbidity burden in kidney cancer patients is high, limited evidence exists on the longitudinal patterns of individual comorbidity prevalence and its impact on overall survival among kidney cancer patients, particularly in Asian populations.MethodsWe included adults diagnosed with kidney cancer between 2010 and 2021 using the Korean nationwide health insurance database. Comorbidities assessed were any 1 of 19 specific medical conditions, diagnosed within 1 year prior to cancer diagnosis. We calculated the incidence and age‐standardized incidence rate of kidney cancer, prevalence of individual medical conditions as single or multiple comorbidities, and overall survival probability of kidney cancer patients over a 12‐year period. We estimated the odds ratio (OR) of having individual and multiple comorbidities with age and sex as independent covariates and adjusted for other comorbidities. Kaplan–Meier curves were used for overall survival at different time frames up to 5 years of follow‐up.ResultsAmong kidney cancer patients (N = 42,740), 68.7% were men, and median (interquartile range) age was 59 (49–68) years. Approximately 76% of patients had at least one comorbidity at the time of cancer diagnosis. Overall, hypertension (51.3%), dyslipidemia (40.2%), mild liver disease (27.4%), diabetes (25.1%), and peptic ulcer disease (18.9%) were the most prevalent comorbidities. The proportion of patients having three or more comorbidities continuously increased from 2010 (29.4%) to 2021 (44.9%). Having more comorbidities was associated with a lower probability of overall survival.ConclusionComorbidities were prevalent in kidney cancer patients, and the proportions of patients with multiple conditions increased over time. Although survival probability increased over time, it was attenuated by having more comorbidities. Our data emphasizes the importance of comprehensive management for both cancer and comorbid conditions in kidney cancer patients. 10.1002/cam4.70421 http://creativecommons.org/licenses/by/4.0/
doi_str_mv 10.1002/cam4.70421
format Artículo Open Access
id wiley_oa_10_1002_cam4_70421
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by/4.0/
publishDate 2024
publisher Wiley
record_format wiley_oa
spellingShingle Longitudinal Trends of Comorbidities and Survival Among Kidney Cancer Patients in Asian Population
Minji Jung
Eunjung Choo
Jinhui Li
Zhengyi Deng
Marvin E. Langston
Sukhyang Lee
Benjamin I. Chung
Cancer Medicine
Longitudinal Trends of Comorbidities and Survival Among Kidney Cancer Patients in Asian Population Minji Jung Eunjung Choo Jinhui Li Zhengyi Deng Marvin E. Langston Sukhyang Lee Benjamin I. Chung Cancer Medicine ABSTRACTBackgroundComorbidity could influence cancer diagnosis, treatment, prognosis, or survival. Although comorbidity burden in kidney cancer patients is high, limited evidence exists on the longitudinal patterns of individual comorbidity prevalence and its impact on overall survival among kidney cancer patients, particularly in Asian populations.MethodsWe included adults diagnosed with kidney cancer between 2010 and 2021 using the Korean nationwide health insurance database. Comorbidities assessed were any 1 of 19 specific medical conditions, diagnosed within 1 year prior to cancer diagnosis. We calculated the incidence and age‐standardized incidence rate of kidney cancer, prevalence of individual medical conditions as single or multiple comorbidities, and overall survival probability of kidney cancer patients over a 12‐year period. We estimated the odds ratio (OR) of having individual and multiple comorbidities with age and sex as independent covariates and adjusted for other comorbidities. Kaplan–Meier curves were used for overall survival at different time frames up to 5 years of follow‐up.ResultsAmong kidney cancer patients (N = 42,740), 68.7% were men, and median (interquartile range) age was 59 (49–68) years. Approximately 76% of patients had at least one comorbidity at the time of cancer diagnosis. Overall, hypertension (51.3%), dyslipidemia (40.2%), mild liver disease (27.4%), diabetes (25.1%), and peptic ulcer disease (18.9%) were the most prevalent comorbidities. The proportion of patients having three or more comorbidities continuously increased from 2010 (29.4%) to 2021 (44.9%). Having more comorbidities was associated with a lower probability of overall survival.ConclusionComorbidities were prevalent in kidney cancer patients, and the proportions of patients with multiple conditions increased over time. Although survival probability increased over time, it was attenuated by having more comorbidities. Our data emphasizes the importance of comprehensive management for both cancer and comorbid conditions in kidney cancer patients. 10.1002/cam4.70421 http://creativecommons.org/licenses/by/4.0/
title Longitudinal Trends of Comorbidities and Survival Among Kidney Cancer Patients in Asian Population
topic Cancer Medicine
url https://onlinelibrary.wiley.com/doi/10.1002/cam4.70421